COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2018 |
| Schlagwörter: | adjuvant / endogenous compound / endoxifen / estrogen receptor alpha / tamoxifen / adult / breast cancer / cancer adjuvant therapy / cancer patient / cancer recurrence / cancer survival / clinician / conference abstract / controlled study / cost effectiveness analysis / death / diagnostic test accuracy study / disease free survival / drug efficacy / drug monitoring / drug therapy / female / human / human tissue / major clinical study / Netherlands / probability / quality adjusted life year / sensitivity analysis / Taverne |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-29202496 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://dspace.library.uu.nl/handle/1874/386988 |
